Quantifying the Impact of Expanded Age Group Campaigns for Polio Eradication

A priority of the Global Polio Eradication Initiative (GPEI) 2013–2018 strategic plan is to evaluate the potential impact on polio eradication resulting from expanding one or more Supplementary Immunization Activities (SIAs) to children beyond age five-years in polio endemic countries. It has been hypothesized that such expanded age group (EAG) campaigns could accelerate polio eradication by eliminating immunity gaps in older children that may have resulted from past periods of low vaccination coverage. Using an individual-based mathematical model, we quantified the impact of EAG campaigns in terms of probability of elimination, reduction in polio transmission and age stratified immunity levels. The model was specifically calibrated to seroprevalence data from a polio-endemic region: Zaria, Nigeria. We compared the impact of EAG campaigns, which depend only on age, to more targeted interventions which focus on reaching missed populations. We found that EAG campaigns would not significantly improve prospects for polio eradication; the probability of elimination increased by 8% (from 24% at baseline to 32%) when expanding three annual SIAs to 5–14 year old children and by 18% when expanding all six annual SIAs. In contrast, expanding only two of the annual SIAs to target hard-to-reach populations at modest vaccination coverage—representing less than one tenth of additional vaccinations required for the six SIA EAG scenario—increased the probability of elimination by 55%. Implementation of EAG campaigns in polio endemic regions would not improve prospects for eradication. In endemic areas, vaccination campaigns which do not target missed populations will not benefit polio eradication efforts.

[1]  J. Fox Modes of action of poliovirus vaccines and relation to resulting immunity. , 1984, Reviews of infectious diseases.

[2]  N. Nathanson,et al.  The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. , 1979, American journal of epidemiology.

[3]  A. Raftery,et al.  Inference for Deterministic Simulation Models: The Bayesian Melding Approach , 2000 .

[4]  E. Ionides,et al.  Successes and shortcomings of polio eradication: a transmission modeling analysis. , 2013, American journal of epidemiology.

[5]  E. Mendelson,et al.  Decline in immunity to polio among young adults. , 2001, Vaccine.

[6]  Karima R. Nigmatulina,et al.  A quantitative survey of the literature on poliovirus infection and immunity. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[7]  M. Böttiger Long-term immunity following vaccination with killed poliovirus vaccine in Sweden, a country with no circulating poliovirus. , 1984, Reviews of infectious diseases.

[8]  Adrian E Raftery,et al.  Estimating and Projecting Trends in HIV/AIDS Generalized Epidemics Using Incremental Mixture Importance Sampling , 2010, Biometrics.

[9]  M. Pallansch,et al.  Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. , 1997, The Journal of infectious diseases.

[10]  S. Nates,et al.  Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously. , 2007, Viral immunology.

[11]  Charles P. Gerba,et al.  Quantitative Microbial Risk Assessment: Second Edition , 2014 .

[12]  L. Duffy,et al.  Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines. , 1993, The Journal of infectious diseases.

[13]  F. Giwa,et al.  Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria. , 2012, Vaccine.

[14]  D. Cohen,et al.  Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization. , 1993, Vaccine.

[15]  P. Fine,et al.  Estimating the Extent of Vaccine-Derived Poliovirus Infection , 2008, PloS one.

[16]  R. Linkins,et al.  Effect of target age of supplemental immunization campaigns on poliomyelitis occurrence in China. , 1997, The Journal of infectious diseases.

[17]  P E Fine,et al.  Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. , 1999, American journal of epidemiology.

[18]  M. Böttiger Polio immunity to killed vaccine: an 18-year follow-up. , 1990, Vaccine.

[19]  N. Grassly,et al.  The role of older children and adults in wild poliovirus transmission , 2014, Proceedings of the National Academy of Sciences.

[20]  J. Rose,et al.  Quantitative Microbial Risk Assessment , 1999 .

[21]  K. Sakae,et al.  The trend of acquired immunity with live poliovirus vaccine and the effect of revaccination: follow-up of vaccinees for ten years. , 1984, Journal of biological standardization.

[22]  J. Qazi,et al.  From Pakistan a line of hope for ‘The Polio Eradication and Endgame Strategic Plan 2013–2018’ , 2016, Infectious diseases.

[23]  Y. Ghendon,et al.  Comparison of the Resistance of the Intestinal Tract to Poliomyelitis virus (Sabin's Strains) in Persons after Naturally and Experimentally Acquired Immunity. , 1961 .

[24]  F. Robbins,et al.  The degree and duration of poliomyelitis virus excretion among vaccinated household contacts of clinical cases of poliomyelitis. , 1958, Pediatrics.

[25]  D. S. Dane,et al.  Vaccination Against Poliomyelitis with Live Virus Vaccines—7 , 1961, British medical journal.